Profil:

Poltreg SA
Publikacja: 2025-02-24 12:56

PolTREG enters partnership with American Kinexum for registration of TREGS therapy in US

Listed healthtech company PolTREG is entering into a cooperation with Kinexum Services LLC for the registration of TREGS therapy in the US, the company announced in a press release. The aim is to provide strategic support in the registration of the TREGS therapy by the US Food and Drug Administration (FDA).


"The cooperation with (...) Kinexum Services LLC, will allow us to adequately prepare for clinical trials and certification of our therapy in the US. We are intensifying our activities in the US market by actively participating in business and medical conferences," said the co-founder and CEO of PolTREG Professor Piotr Trzonkowski, quoted in the press release.

"Over the past year, we have significantly increased the visibility of PolTREG among the world's 50 largest pharmaceutical companies with whom we have initiated contacts. We are in talks with some of them on strategic cooperation," he added.

The CEO added that in the PreTREG project (pre-diabetes type 1), the company expects to recruit the first patient for phase II clinical trials in the coming weeks.

PolTREG is also in talks with several leading US clinical centres to establish collaborations for entry into the US market.

mbi/ ao/

© Copyright
Wszelkie materiały (w szczególności depesze agencyjne, zdjęcia, grafiki, filmy) zamieszczone w niniejszym Portalu PAP Biznes chronione są przepisami ustawy z dnia 4 lutego 1994 r. o prawie autorskim i prawach pokrewnych oraz ustawy z dnia 27 lipca 2001 r. o ochronie baz danych. Materiały te mogą być wykorzystywane wyłącznie na postawie stosownych umów licencyjnych. Jakiekolwiek ich wykorzystywanie przez użytkowników Portalu, poza przewidzianymi przez przepisy prawa wyjątkami, w szczególności dozwolonym użytkiem osobistym, bez ważnej umowy licencyjnej jest zabronione.

Waluty

Waluta Kurs Zmiana
1 CHF 4,3811 -0,38%
1 EUR 4,1783 -0,28%
1 GBP 4,9986 -0,58%
100 JPY 2,5720 0,02%
1 USD 3,8606 -0,59%

Powiązane